DLL3 as a candidate gene for vertebral malformations.

VACTERL anomalies in patients with esophageal atresia: an updated delineation of the spectrum and review of the literature. Pediatr Surg Int (2007) 1.24

Clinical, genetic and environmental factors associated with congenital vertebral malformations. Mol Syndromol (2013) 0.97

Genetic aspects of congenital and idiopathic scoliosis. Scientifica (Cairo) (2012) 0.84

Ventricular septal defect closure in a patient with VACTERL syndrome: anticipating sequelae in a rare genetic disorder. Tex Heart Inst J (2008) 0.81

Animal models for scoliosis research: state of the art, current concepts and future perspective applications. Eur Spine J (2012) 0.79

Lack of evidence of WNT3A as a candidate gene for congenital vertebral malformations. Scoliosis (2007) 0.78

The genetic landscape and clinical implications of vertebral anomalies in VACTERL association. J Med Genet (2016) 0.77

Five known tagging DLL3 SNPs are not associated with congenital scoliosis: A case-control association study in a Chinese Han population. Medicine (Baltimore) (2016) 0.75

p53 mutant mice that display early ageing-associated phenotypes. Nature (2002) 10.05

The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity (2009) 4.51

CYP4F2 genetic variant alters required warfarin dose. Blood (2008) 4.23

Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss. Nat Genet (2011) 3.97

TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci U S A (2009) 3.70

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study. Lancet (2013) 3.21

Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat (2009) 2.81

Clinical genetics provider real-time workflow study. Genet Med (2008) 2.49

Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. N Engl J Med (2010) 2.44

Evaluation of genetic factors for warfarin dose prediction. Clin Med Res (2007) 2.37

Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis. J Bone Miner Res (2009) 2.24

Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: a population-based experience. Thromb Res (2011) 2.10

A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data. Clin Med Res (2005) 2.05

A timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureus. PLoS Pathog (2010) 2.04

Birds, migration and emerging zoonoses: west nile virus, lyme disease, influenza A and enteropathogens. Clin Med Res (2003) 2.00

Paired analysis of TCRα and TCRβ chains at the single-cell level in mice. J Clin Invest (2010) 1.87

Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial. Lancet (2013) 1.82

The co-occurrence of early onset Parkinson disease and 22q11.2 deletion syndrome. Am J Med Genet A (2009) 1.82

Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype. Pharmacogenetics (2004) 1.75

Construction of atorvastatin dose-response relationships using data from a large population-based DNA biobank. Basic Clin Pharmacol Toxicol (2007) 1.64

Intraocular pressure response to topical beta-blockers associated with an ADRB2 single-nucleotide polymorphism. Arch Ophthalmol (2008) 1.57

Pharmacogenetic challenges for the health care system. Health Aff (Millwood) (2002) 1.48

A fair and balanced view of spine fusion surgery. Spine J (2004) 1.46

Maternal vitamin K deficient embryopathy: association with hyperemesis gravidarum and Crohn disease. Am J Med Genet A (2013) 1.46

Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am J Hum Genet (2004) 1.45

Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity. Antimicrob Agents Chemother (2012) 1.40

Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damage. Pharmacogenet Genomics (2005) 1.38

Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy. Thromb Haemost (2011) 1.35

Congenital and idiopathic scoliosis: clinical and genetic aspects. Clin Med Res (2003) 1.31

Gene therapy for cancer treatment: past, present and future. Clin Med Res (2006) 1.30

Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen. Hum Mol Genet (2012) 1.29

Natural history of rhizomelic chondrodysplasia punctata. Am J Med Genet A (2003) 1.27

Infective endocarditis: rationale for revised guidelines for antibiotic prophylaxis. Clin Med Res (2009) 1.25

The diagnostic challenge of progressive pseudorheumatoid dysplasia (PPRD): a review of clinical features, radiographic features, and WISP3 mutations in 63 affected individuals. Am J Med Genet C Semin Med Genet (2012) 1.23

Radiation dose reduction to medical staff during vertebroplasty: a review of techniques and methods to mitigate occupational dose. Spine (Phila Pa 1976) (2003) 1.22

Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci. Prostate (2003) 1.22

Alendronate treatment of the brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation. J Bone Miner Res (2009) 1.21

Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy. Breast Cancer Res Treat (2008) 1.21

Majewski osteodysplastic primordial dwarfism type II (MOPD II): natural history and clinical findings. Am J Med Genet A (2004) 1.20

Fatal brain abscess due to community-associated methicillin-resistant Staphylococcus aureus strain USA300. Clin Infect Dis (2007) 1.20

Complete genome sequence and lifestyle of black-pigmented Corynebacterium aurimucosum ATCC 700975 (formerly C. nigricans CN-1) isolated from a vaginal swab of a woman with spontaneous abortion. BMC Genomics (2010) 1.20

Emergence and spread of community-associated methicillin-resistant Staphylococcus aureus in rural Wisconsin, 1989 to 1999. J Clin Microbiol (2004) 1.20

Stillbirth classification--developing an international consensus for research: executive summary of a National Institute of Child Health and Human Development workshop. Obstet Gynecol (2009) 1.20

FMR1 CGG expansions: prevalence and sex ratios. Am J Med Genet B Neuropsychiatr Genet (2013) 1.19

Advances in understanding etiology of achondroplasia and review of management. Curr Opin Pediatr (2007) 1.19

Evidence of multiple virulence subtypes in nosocomial and community-associated MRSA genotypes in companion animals from the upper midwestern and northeastern United States. Clin Med Res (2010) 1.18

A novel locus for adolescent idiopathic scoliosis on chromosome 12p. J Orthop Res (2009) 1.13

Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse. Bone (2005) 1.13

Quantitative trait loci for biomechanical performance and femoral geometry in an intercross of recombinant congenic mice: restriction of the Bmd7 candidate interval. FASEB J (2009) 1.11

Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway. Cancer Res (2009) 1.10

Mutations in ZIC2 in human holoprosencephaly: description of a novel ZIC2 specific phenotype and comprehensive analysis of 157 individuals. J Med Genet (2009) 1.10

Calciphylaxis in the absence of end-stage renal disease. Endocr Pract (2006) 1.09

Type 2 diabetes mellitus, glycemic control, and cancer risk. Eur J Cancer Prev (2014) 1.07

Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia. J Infect Dis (2012) 1.06

Genetic and orthopedic aspects of collagen disorders. Curr Opin Pediatr (2009) 1.05

Virchow's contribution to the understanding of thrombosis and cellular biology. Clin Med Res (2010) 1.05

Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control (2012) 1.04

Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model. Pediatr Res (2002) 1.03

Shift in Staphylococcus aureus clone linked to an infected tattoo. Emerg Infect Dis (2006) 1.02

Intraocular pressure response to medication in a clinical setting: the Marshfield Clinic Personalized Medicine Research Project. J Glaucoma (2008) 1.02

Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. Cancer Causes Control (2012) 1.01

Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9. J Altern Complement Med (2005) 0.99

Impact of age, CYP2C9 genotype and concomitant medication on the rate of rise for prothrombin time during the first 30 days of warfarin therapy. Clin Med Res (2005) 0.99

Applying case definition criteria to irritable bowel syndrome. Clin Med Res (2008) 0.99

Diffuse idiopathic skeletal hyperostosis: a rare cause of Dysphagia, airway obstruction, and dysphonia. J Am Coll Surg (2006) 0.99

Hexa-D-arginine treatment increases 7B2•PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype. J Bone Miner Res (2013) 0.99

Screening monoclonal antibodies for cross-reactivity in the ferret model of influenza infection. J Immunol Methods (2008) 0.98

Progress in the understanding of the genetic etiology of vertebral segmentation disorders in humans. Ann N Y Acad Sci (2009) 0.98

Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet. PLoS One (2012) 0.98

Interobserver reproducibility of criteria for vertebral body exclusion. J Bone Miner Res (2004) 0.98

Linkage mapping of femoral material properties in a reciprocal intercross of HcB-8 and HcB-23 recombinant mouse strains. Bone (2010) 0.97

Medical applications of transforming growth factor-beta. Clin Med Res (2003) 0.97

Genetic variants of Anaplasma phagocytophilum infecting dogs in Western Washington State. J Clin Microbiol (2005) 0.96

Spondylometaphyseal dysplasia with cone-rod dystrophy. Am J Med Genet A (2004) 0.96

Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res (2005) 0.95

Necrotizing fasciitis due to a methicillin-sensitive Staphylococcus aureus isolate harboring an enterotoxin gene cluster. J Clin Microbiol (2006) 0.95

Linkage mapping of principal components for femoral biomechanical performance in a reciprocal HCB-8 × HCB-23 intercross. Bone (2010) 0.95

A missense T (Brachyury) mutation contributes to vertebral malformations. J Bone Miner Res (2008) 0.95

Understanding the pharmacogenetic approach to warfarin dosing. Heart Fail Rev (2008) 0.94